Транскраниальная магнитная стимуляция в терапии резиcтентной к лечению депрессии

Of the 15 patients who participated in the study, the mean HAM-D score decreased from 29 at baseline to 11 after the treatment period. In 86% of patients, the HAM-D score decreased by at least 50%, and 57% of all patients reached remission. Three patients experienced tolerable focal pain, and this disappeared during the treatment period. No patients experienced seizure or manic symptoms.

rTMS May Be Effective in Patients With Treatment-Resistant Bipolar Depression